<DOC>
	<DOCNO>NCT00159445</DOCNO>
	<brief_summary>This study patient colorectal cancer spread increase size standard treatment . This study do find long take tumor grow treatment chemotherapy drug capecitabine gemcitabine . Capecitabine chemotherapy drug approve FDA treatment colorectal cancer . We add another drug ( call gemcitabine ) , approve FDA treatment cancer pancreas see ability capecitabine shrink tumor improve add gemcitabine . The side effect combination also evaluate . Another purpose study measure level certain substance affect body reacts chemotherapy agent cancer cell ( tumor ) . In addition , gene ( cell 's blueprint substance ) also evaluate blood .</brief_summary>
	<brief_title>Capecitabine Gemcitabine Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Histologically confirm metastatic adenocarcinoma colon rectum , measurable disease . The primary histologic diagnosis sufficient clear evidence image and/or marker metastatic disease site . Patients must fail CPT11 oxaliplatin base therapy . Patients must receive least two prior chemotherapy regimen advance disease ( complete &gt; 4 week prior enrollment ) . Tumor must accessible biopsy paraffin embed tissue must available review . SWOG performance status 02 . AGC &gt; 1000 , platelets &gt; 100,000 . Total bilirubin &lt; 3 x upper limit normal . Transaminase ( AST and/or ALT ) &lt; 2 x upper limit normal &lt; 5 x upper limit normal patient liver metastasis . Patients must measure calculated creatinine clearance great 35 mL/min obtain within 28 day prior registration . Age great equal 18 year Patients hemoglobin &gt; 9 g/dL ; patient may transfuse achieve level hemoglobin . Except cancerrelated abnormality , patient unstable preexist major medical condition . History malignancy colon rectal cancer , except adequately treat basal cell squamous cell skin cancer , situ cervical cancer , cancer patient diseasefree five year . Patients brain metastasis . History recent ( within one year ) myocardial infarction evidence congestive heart failure . Patients psychological , familial , sociological , geographical condition permit medical followup compliance study protocol . Patients immediate lifethreatening complication malignancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>